C-APLI

T:APLI - APPILI THERAPEUTICS INC. J - https://www.appilitherapeutics.com

04:43:23 EDT

Sym-X	Bid - Ask					Last	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
APLI - T	50.0	0.015	·	0.02	895.0	0.015	37.3	1	9	0.02 0.02 0.015	0.045 0.01	15:59:58	Jun 25	15 min RT 2¢
TSX - T	50.0	0.015	·	0.02	895.0	0.015	1.0		1	0.015 0.015 0.015	0.045 0.01	15:59:58		15 min
Omega - O						0.015	35.0	1	3	0.02 0.02 0.015		14:43:28		15 min
CXD - D						0.015	0.05		2			Apr 04		15 min
TriAct - M						0.015	1.2		3			Sep 11/20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - All 9 today

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:58	T	0.015		1,000	80 National Bank	80 National Bank	KL
14:43:28	M	0.015		500	7 TD Sec	79 CIBC	E
14:43:28	O	0.015		2,000	1 Anonymous	79 CIBC	K
14:41:52	M	0.015		600	80 National Bank	79 CIBC	E
14:41:52	O	0.015		8,000	1 Anonymous	79 CIBC	K
14:38:05	M	0.015		123	7 TD Sec	7 TD Sec	E
14:22:42	D	0.02	0.005	40	124 Questrade	7 TD Sec	E
11:28:37	O	0.02	0.005	25,000	79 CIBC	1 Anonymous	K
09:30:01	D	0.01	-0.005	8	80 National Bank	80 National Bank	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2025-06-25 20:49	C:APLI	0.015	SEDAR Annual Information Form802	SEDAR Annual Information Form
2025-06-25 20:39	C:APLI	0.015	SEDAR MD & A815	SEDAR MD & A
2025-06-25 20:26	C:APLI	0.015	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-06-25 18:04	C:APLI	0.015	News Release200	Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results
2025-05-30 16:19	C:APLI	0.015	News Release200	Appili terminates arrangement with Aditxt
2025-05-20 02:24	C:APLI	0.03	News Release200	Appili to receive termination fee from Aditxt
2025-05-01 07:34	C:APLI	0.03	News Release200	Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia
2025-04-28 17:47	C:APLI	0.03	News Release200	Appili Therapeutics granted patents in U.S., Mexico
2025-04-02 17:23	C:APLI	0.03	News Release200	Appili president to join Aditxt's April 4 update
2025-03-18 17:35	C:APLI	0.035	News Release200	Appili Therapeutics submits U.S. funding applications
2025-02-14 17:59	C:APLI	0.03	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-02-14 17:53	C:APLI	0.03	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-02-14 17:06	C:APLI	0.03	News Release200	Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
2024-12-12 08:15	C:APLI	0.035	News Release200	Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials
2024-11-19 16:31	C:APLI	0.03	News Release200	Appili receives final court order for Aditxt deal
2024-11-14 08:35	C:APLI	0.035	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-11-14 08:29	C:APLI	0.035	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-11-14 07:15	C:APLI	0.035	News Release200	Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
2024-11-08 08:30	C:APLI	0.04	News Release200	Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
2024-11-07 08:30	C:APLI	0.035	News Release200	Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders

Date ET

Symbol

Price

Type

Headline

2025-06-25 20:49

C:APLI

0.015

SEDAR Annual Information Form

2025-06-25 20:39

C:APLI

0.015